http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1598070-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 |
| filingDate | 2004-04-30^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6353dc1d145f08fc42e14efe2c0c205e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1083c3a9d7024845408b64a4c857566f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f141e5259570d89c1213a505e75f88c |
| publicationDate | 2005-11-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1598070-A1 |
| titleOfInvention | Administration of enoxaparin sodium to patients 75 years and older with ST-segment elevation myocardial infarction |
| abstract | Methods for treating ST-segment elevation myocardial infarction in a human patient 75 years of age or older. The methods comprise administering a dose of less than 1 mg per kg body weight, about .75 mg per kg of body weight, or .75 mg per kg of body weight of enoxaparin sodium by subcutaneous injection approximately every twelve hours for a therapeutic dosing period. The methods may include fibrinolytic therapy. The treatment methods may be used to prevent one or more of, mortality, myocardial re-infarction, myocardial ischemia, stroke, or severe congestive heart failure. Articles of manufacture for use in connection with treating ST-segment elevation myocardial infarction in a human patient 75 years of age or older are also disclosed. The articles of manufacture comprise enoxaparin sodium, and instructions designed to achieve administration to a patient of a dose of less than 1 mg per kg body weight, about .75 mg per kg of body weight, or .75 mg per kg of body weight of enoxaparin sodium, by subcutaneous injection approximately every twelve hours for a therapeutic dosing period. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109157529-A |
| priorityDate | 2004-04-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 79 of 79.